{"filing":{"accession_number":"0001104659-26-064518","cik":"0000882095","ticker":"GILD","company_name":"GILEAD SCIENCES, INC.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"tm2615045d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882095/000110465926064518/tm2615045d1_8k.htm"},"events":[{"id":9737,"run_id":8535,"accession_number":"0001104659-26-064518","anchor_item_number":"1.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"summary":"Gilead entered into an Eleventh Supplemental Indenture on May 20, 2026, governing the issuance of $3 billion in aggregate principal amount of senior notes across four series (2028, 2029, 2031, and 2034 notes) with interest rates ranging from 4.250% to 4.900%. The company intends to use net proceeds for general corporate purposes including potential acquisitions and strategic transactions.","company_name":"GILEAD SCIENCES, INC.","ticker":"GILD","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":522,"accession_number":"0001104659-26-064518","item_number":"1.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"Gilead entered into an Eleventh Supplemental Indenture on May 20, 2026, governing the issuance of $3 billion in aggregate principal amount of senior notes across four series (2028, 2029, 2031, and 2034 notes) with interest rates ranging from 4.250% to 4.900%. While this is a material debt issuance disclosed under Item 1.01 (Entry into a Material Definitive Agreement), it does not fit cleanly into the M\u0026A activity category—it is a financing transaction rather than an acquisition, disposition, or change of control. The company intends to use net proceeds for general corporate purposes including potential acquisitions and strategic transactions, but the primary disclosed event is the debt financing itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:08.587603+00:00","company_name":"","ticker":null,"filing_date":""},{"id":523,"accession_number":"0001104659-26-064518","item_number":"2.03","item_title":"Creation of a Direct","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation or off-balance sheet arrangement, but the actual substance is incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific event type cannot be determined with confidence. Item 1.01 typically covers material agreements (M\u0026A, debt issuance, or other transactions), so this could be ma_activity, covenant_breach, or another material event. Given the ambiguity and the incorporation-by-reference structure, other_material is the most defensible classification pending review of Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:08.587603+00:00","company_name":"","ticker":null,"filing_date":""},{"id":524,"accession_number":"0001104659-26-064518","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses entry into an underwriting agreement for issuance and sale of notes by Gilead Sciences on May 14, 2026, with major underwriters (Barclays, BofA, Citigroup). While this represents a material debt or equity issuance, the Item 8.01 disclosure is sparse and does not specify the security type, amount, or terms. This appears to be a debt offering (referenced as \"Notes\") but lacks sufficient detail to confirm it as a dilutive equity issuance; it is classified as other_material given the material financing activity disclosed but ambiguity about the precise instrument and its dilutive impact.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:08.587603+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":522,"accession_number":"0001104659-26-064518","item_number":"1.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"Gilead entered into an Eleventh Supplemental Indenture on May 20, 2026, governing the issuance of $3 billion in aggregate principal amount of senior notes across four series (2028, 2029, 2031, and 2034 notes) with interest rates ranging from 4.250% to 4.900%. While this is a material debt issuance disclosed under Item 1.01 (Entry into a Material Definitive Agreement), it does not fit cleanly into the M\u0026A activity category—it is a financing transaction rather than an acquisition, disposition, or change of control. The company intends to use net proceeds for general corporate purposes including potential acquisitions and strategic transactions, but the primary disclosed event is the debt financing itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:08.587603+00:00","company_name":"GILEAD SCIENCES, INC.","ticker":"GILD","filing_date":"2026-05-20"},{"id":523,"accession_number":"0001104659-26-064518","item_number":"2.03","item_title":"Creation of a Direct","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation or off-balance sheet arrangement, but the actual substance is incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific event type cannot be determined with confidence. Item 1.01 typically covers material agreements (M\u0026A, debt issuance, or other transactions), so this could be ma_activity, covenant_breach, or another material event. Given the ambiguity and the incorporation-by-reference structure, other_material is the most defensible classification pending review of Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:08.587603+00:00","company_name":"GILEAD SCIENCES, INC.","ticker":"GILD","filing_date":"2026-05-20"},{"id":524,"accession_number":"0001104659-26-064518","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses entry into an underwriting agreement for issuance and sale of notes by Gilead Sciences on May 14, 2026, with major underwriters (Barclays, BofA, Citigroup). While this represents a material debt or equity issuance, the Item 8.01 disclosure is sparse and does not specify the security type, amount, or terms. This appears to be a debt offering (referenced as \"Notes\") but lacks sufficient detail to confirm it as a dilutive equity issuance; it is classified as other_material given the material financing activity disclosed but ambiguity about the precise instrument and its dilutive impact.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:08.587603+00:00","company_name":"GILEAD SCIENCES, INC.","ticker":"GILD","filing_date":"2026-05-20"}]}